FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4323652159> ?p ?o ?g. }

• W4323652159 endingPage "505" @default.
• W4323652159 startingPage "497" @default.
• W4323652159 abstract "The efficacy of pre-operative systemic treatment (PST) combined with immune checkpoint inhibition (ICI) for triple-negative breast cancer (TNBC) has been recognized recently as being independent of the degree of programmed death ligand-1 (PD-L1) positivity of infiltrating immune cells, especially for patients with axillary lymph node metastasis (ALNM).TNBC patients with ALNM were treated surgically between 2002 and 2016 in our facility (n = 109), of whom 38 received PST before resection. The presence of tumor-infiltrating lymphocytes (TILs) expressing CD3, CD8, CD68, PD-L1 (detected by antibody SP142) and FOXP3 at primary and metastatic LN sites was quantified.The size of invasive tumor and the number of metastatic axillary LN were confirmed as prognostic markers. The numbers of both CD8+ and FOXP3+ TILs at primary sites were also recognized as prognostic markers, especially for overall survival (OS) (CD8, p = 0.026; FOXP3, p < 0.001). The presence of CD8+, FOXP3+ and PD-L1+ cells was better maintained in LN after PST and may contribute to improved antitumor immunity. Provided they were present as clusters of ≥ 70 positive cells, even < 1% of immune cells expressing PD-L1 at primary sites predicted a more favorable prognosis for both disease-free survival (DFS) (p = 0.004) and OS (p = 0.020). This was the case not only for 30 matched surgical patients, but also in all 71 surgical only patients (DFS: p < 0.001 and OS: p = 0.002).PD-L1+ , CD8+ or FOXP3+ immune cells in the tumor microenvironment (TME) at both primary and metastatic sites are significant on prognosis, which could be a clue to expect the potential for better responses to the combination of chemotherapy and ICI, especially for patients with ALNM." @default.
• W4323652159 created "2023-03-10" @default.
• W4323652159 creator A5004015853 @default.
• W4323652159 creator A5004344858 @default.
• W4323652159 creator A5008946028 @default.
• W4323652159 creator A5015889946 @default.
• W4323652159 creator A5030058872 @default.
• W4323652159 creator A5030411769 @default.
• W4323652159 creator A5037142583 @default.
• W4323652159 creator A5037467101 @default.
• W4323652159 creator A5046833051 @default.
• W4323652159 creator A5065803170 @default.
• W4323652159 creator A5068445895 @default.
• W4323652159 creator A5084909567 @default.
• W4323652159 date "2023-03-09" @default.
• W4323652159 modified "2023-10-14" @default.
• W4323652159 title "Programmed death ligand 1-positive immune cells in primary tumor or metastatic axillary lymph nodes can predict prognosis of triple-negative breast cancer even when present at < 1% in the tumor region" @default.
• W4323652159 cites W2169509228 @default.
• W4323652159 cites W2347141054 @default.
• W4323652159 cites W2613186675 @default.
• W4323652159 cites W2936616584 @default.
• W4323652159 cites W3006930853 @default.
• W4323652159 cites W3080682266 @default.
• W4323652159 cites W3087393791 @default.
• W4323652159 cites W3112001494 @default.
• W4323652159 cites W3127482120 @default.
• W4323652159 cites W3151427897 @default.
• W4323652159 cites W3174412391 @default.
• W4323652159 cites W3186836245 @default.
• W4323652159 cites W4285992810 @default.
• W4323652159 doi "https://doi.org/10.1007/s12282-023-01442-9" @default.
• W4323652159 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36892732" @default.
• W4323652159 hasPublicationYear "2023" @default.
• W4323652159 type Work @default.
• W4323652159 citedByCount "0" @default.
• W4323652159 crossrefType "journal-article" @default.
• W4323652159 hasAuthorship W4323652159A5004015853 @default.
• W4323652159 hasAuthorship W4323652159A5004344858 @default.
• W4323652159 hasAuthorship W4323652159A5008946028 @default.
• W4323652159 hasAuthorship W4323652159A5015889946 @default.
• W4323652159 hasAuthorship W4323652159A5030058872 @default.
• W4323652159 hasAuthorship W4323652159A5030411769 @default.
• W4323652159 hasAuthorship W4323652159A5037142583 @default.
• W4323652159 hasAuthorship W4323652159A5037467101 @default.
• W4323652159 hasAuthorship W4323652159A5046833051 @default.
• W4323652159 hasAuthorship W4323652159A5065803170 @default.
• W4323652159 hasAuthorship W4323652159A5068445895 @default.
• W4323652159 hasAuthorship W4323652159A5084909567 @default.
• W4323652159 hasBestOaLocation W43236521591 @default.
• W4323652159 hasConcept C121608353 @default.
• W4323652159 hasConcept C126322002 @default.
• W4323652159 hasConcept C143998085 @default.
• W4323652159 hasConcept C167672396 @default.
• W4323652159 hasConcept C203014093 @default.
• W4323652159 hasConcept C2776107976 @default.
• W4323652159 hasConcept C2777649267 @default.
• W4323652159 hasConcept C2778326572 @default.
• W4323652159 hasConcept C2779013556 @default.
• W4323652159 hasConcept C2779727006 @default.
• W4323652159 hasConcept C2780110267 @default.
• W4323652159 hasConcept C2780140570 @default.
• W4323652159 hasConcept C2780283643 @default.
• W4323652159 hasConcept C2780849966 @default.
• W4323652159 hasConcept C502942594 @default.
• W4323652159 hasConcept C530470458 @default.
• W4323652159 hasConcept C71924100 @default.
• W4323652159 hasConcept C8891405 @default.
• W4323652159 hasConceptScore W4323652159C121608353 @default.
• W4323652159 hasConceptScore W4323652159C126322002 @default.
• W4323652159 hasConceptScore W4323652159C143998085 @default.
• W4323652159 hasConceptScore W4323652159C167672396 @default.
• W4323652159 hasConceptScore W4323652159C203014093 @default.
• W4323652159 hasConceptScore W4323652159C2776107976 @default.
• W4323652159 hasConceptScore W4323652159C2777649267 @default.
• W4323652159 hasConceptScore W4323652159C2778326572 @default.
• W4323652159 hasConceptScore W4323652159C2779013556 @default.
• W4323652159 hasConceptScore W4323652159C2779727006 @default.
• W4323652159 hasConceptScore W4323652159C2780110267 @default.
• W4323652159 hasConceptScore W4323652159C2780140570 @default.
• W4323652159 hasConceptScore W4323652159C2780283643 @default.
• W4323652159 hasConceptScore W4323652159C2780849966 @default.
• W4323652159 hasConceptScore W4323652159C502942594 @default.
• W4323652159 hasConceptScore W4323652159C530470458 @default.
• W4323652159 hasConceptScore W4323652159C71924100 @default.
• W4323652159 hasConceptScore W4323652159C8891405 @default.
• W4323652159 hasIssue "3" @default.
• W4323652159 hasLocation W43236521591 @default.
• W4323652159 hasLocation W43236521592 @default.
• W4323652159 hasLocation W43236521593 @default.
• W4323652159 hasOpenAccess W4323652159 @default.
• W4323652159 hasPrimaryLocation W43236521591 @default.
• W4323652159 hasRelatedWork W1999292713 @default.
• W4323652159 hasRelatedWork W2139975046 @default.
• W4323652159 hasRelatedWork W2224319365 @default.
• W4323652159 hasRelatedWork W2317787856 @default.
• W4323652159 hasRelatedWork W2376078656 @default.
• W4323652159 hasRelatedWork W2554176272 @default.
• W4323652159 hasRelatedWork W3044626609 @default.

• next